Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
mgrR5duJLEPrwuKQ
Listen
